ATE312611T1 - Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen - Google Patents
Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungenInfo
- Publication number
- ATE312611T1 ATE312611T1 AT98921544T AT98921544T ATE312611T1 AT E312611 T1 ATE312611 T1 AT E312611T1 AT 98921544 T AT98921544 T AT 98921544T AT 98921544 T AT98921544 T AT 98921544T AT E312611 T1 ATE312611 T1 AT E312611T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- mizolastine
- inflammation
- treatment
- production
- Prior art date
Links
- PVLJETXTTWAYEW-UHFFFAOYSA-N Mizolastine Chemical compound N=1C=CC(=O)NC=1N(C)C(CC1)CCN1C1=NC2=CC=CC=C2N1CC1=CC=C(F)C=C1 PVLJETXTTWAYEW-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001144 mizolastine Drugs 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 abstract 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704801A FR2762214B1 (fr) | 1997-04-17 | 1997-04-17 | Utilisation de la mizolastine pour la preparation d'un medicament destine au traitement de l'inflammation |
| PCT/FR1998/000765 WO1998047511A1 (fr) | 1997-04-17 | 1998-04-16 | Utilisation de la mizolastine pour la preparation d'un medicament destine au traitement de l'inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312611T1 true ATE312611T1 (de) | 2005-12-15 |
Family
ID=9506075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98921544T ATE312611T1 (de) | 1997-04-17 | 1998-04-16 | Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6140335A (de) |
| EP (1) | EP1007047B1 (de) |
| JP (2) | JP2001523242A (de) |
| AT (1) | ATE312611T1 (de) |
| AU (1) | AU7436098A (de) |
| DE (1) | DE69832796T2 (de) |
| DK (1) | DK1007047T3 (de) |
| ES (1) | ES2253816T3 (de) |
| FR (1) | FR2762214B1 (de) |
| WO (1) | WO1998047511A1 (de) |
| ZA (1) | ZA983211B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0958820A1 (de) * | 1998-05-19 | 1999-11-24 | Sanofi-Synthelabo | Verwendung von einem Imidazolderivat zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunerkrankungen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2587029B1 (fr) * | 1985-09-11 | 1987-10-30 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
-
1997
- 1997-04-17 FR FR9704801A patent/FR2762214B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-16 EP EP98921544A patent/EP1007047B1/de not_active Expired - Lifetime
- 1998-04-16 ZA ZA983211A patent/ZA983211B/xx unknown
- 1998-04-16 DK DK98921544T patent/DK1007047T3/da active
- 1998-04-16 AT AT98921544T patent/ATE312611T1/de active
- 1998-04-16 JP JP54514798A patent/JP2001523242A/ja not_active Withdrawn
- 1998-04-16 ES ES98921544T patent/ES2253816T3/es not_active Expired - Lifetime
- 1998-04-16 WO PCT/FR1998/000765 patent/WO1998047511A1/fr not_active Ceased
- 1998-04-16 AU AU74360/98A patent/AU7436098A/en not_active Abandoned
- 1998-04-16 US US09/403,005 patent/US6140335A/en not_active Expired - Lifetime
- 1998-04-16 DE DE69832796T patent/DE69832796T2/de not_active Expired - Lifetime
-
2009
- 2009-07-31 JP JP2009179561A patent/JP5271188B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA983211B (en) | 1998-10-22 |
| EP1007047A1 (de) | 2000-06-14 |
| FR2762214B1 (fr) | 2000-10-06 |
| DE69832796T2 (de) | 2006-08-31 |
| JP5271188B2 (ja) | 2013-08-21 |
| FR2762214A1 (fr) | 1998-10-23 |
| DK1007047T3 (da) | 2006-05-08 |
| US6140335A (en) | 2000-10-31 |
| AU7436098A (en) | 1998-11-13 |
| JP2001523242A (ja) | 2001-11-20 |
| JP2009292827A (ja) | 2009-12-17 |
| WO1998047511A1 (fr) | 1998-10-29 |
| DE69832796D1 (de) | 2006-01-19 |
| EP1007047B1 (de) | 2005-12-14 |
| ES2253816T3 (es) | 2006-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| DE69636343D1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
| DE59310327D1 (de) | Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura | |
| DE69507029D1 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten | |
| ATE213164T1 (de) | Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids | |
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| ATE144420T1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
| ATE217197T1 (de) | Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa | |
| DE59401401D1 (de) | Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit | |
| ATE249828T1 (de) | Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen | |
| DE59508961D1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
| ATE252897T1 (de) | Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen | |
| BG105275A (en) | Tan-1057 derivatives | |
| DE69329687D1 (de) | Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus | |
| AU3862997A (en) | Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof | |
| NO990450L (no) | Behandling av sinnslidelser | |
| ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
| DE50103012D1 (de) | Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen | |
| ATE194076T1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
| ATE189385T1 (de) | Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems | |
| DE69832796D1 (de) | Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen | |
| ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
| ATE215368T1 (de) | Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1007047 Country of ref document: EP |